(Q37897692)

25 August 2017

1 reference

title

Perfusion SPECT and FDG-PET. (English)

1 reference

Fluorodeoxyglucose Positron Emission Tomography

25 August 2017

main subject

1 reference

Karl Herholz

1

1 reference

25 August 2017

publication date

1 September 2011

1 reference

International Psychogeriatrics

25 August 2017

published in

1 reference

25 August 2017

volume

23 Suppl 2

1 reference

25 August 2017

page(s)

S25-31

1 reference

Sequential relationships between grey matter and white matter atrophy and brain metabolic abnormalities in early Alzheimer's disease

25 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000937

The retention mechanism of technetium-99m-HM-PAO: intracellular reaction with glutathione

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000937

Relationships between hippocampal atrophy, white matter disruption, and gray matter hypometabolism in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000937

Microsphere analysis of local cerebral and extracerebral blood flow after complete ischemia of the cat brain for one hour

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000937

Advancement in PET quantification using 3D-OP-OSEM point spread function reconstruction with the HRRT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000937

EFNS guidelines for the diagnosis and management of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000937

EANM procedure guidelines for PET brain imaging using [18F]FDG, version 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000937

Regional cerebral metabolism in early Alzheimer's disease with clinically significant apathy or depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000937

Update on the biomarker core of the Alzheimer's Disease Neuroimaging Initiative subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000937

A clinical role for 99mTc-HMPAO SPECT in the investigation of dementia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000937

Discrimination between Alzheimer dementia and controls by automated analysis of multicenter FDG PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000937

Brain perfusion SPECT in patients with mild cognitive impairment and Alzheimer's disease: comparison of a semiquantitative and a visual evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000937

Positron emission tomography in clinical neurology

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000937

Relation between physiological function and energy metabolism in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000937

Cerebral glucose metabolism in preclinical and prodromal Alzheimer’s disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000937

Multicenter standardized 18F-FDG PET diagnosis of mild cognitive impairment, Alzheimer's disease, and other dementias

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000937

Reduced hippocampal metabolism in MCI and AD: automated FDG-PET image analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000937

Multivariate and univariate neuroimaging biomarkers of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000937

Alzheimer's disease versus dementia with Lewy bodies: cerebral metabolic distinction with autopsy confirmation

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000937

Stability of metabolic and neuropsychological asymmetries in dementia of the Alzheimer type

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000937

The topography of grey matter involvement in early and late onset Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000937

FDG-PET improves accuracy in distinguishing frontotemporal dementia and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000937

Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000937

Optimized data preprocessing for multivariate analysis applied to 99mTc-ECD SPECT data sets of Alzheimer's patients and asymptomatic controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000937

Predicting the accuracy of a diagnosis of Alzheimer's disease with 99mTc HMPAO single photon emission computed tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000937

Metabolic patterns associated with the clinical response to galantamine therapy: a fludeoxyglucose f 18 positron emission tomographic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000937

Functional brain imaging in the dementias: role in early detection, differential diagnosis, and longitudinal studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000937

Accuracy of single-photon emission computed tomography in differentiating frontotemporal dementia from Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000937

Longitudinal PET Evaluation of Cerebral Metabolic Decline in Dementia: A Potential Outcome Measure in Alzheimer's Disease Treatment Studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000937

Occipital hypoperfusion on SPECT in dementia with Lewy bodies but not AD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000937

Report of the task force on designing clinical trials in early (predementia) AD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000937

Neural activity triggers neuronal oxidative metabolism followed by astrocytic glycolysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000937

Effect of phenserine treatment on brain functional activity and amyloid in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000937

Preclinical prediction of Alzheimer's disease using SPECT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000937

SPECT perfusion imaging in the diagnosis of Alzheimer's disease: a clinical-pathologic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000937

Longitudinal studies of regional cerebral metabolism in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000937

Topography of cross-sectional and longitudinal glucose metabolic deficits in Alzheimer's disease. Pathophysiologic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000937

21 January 2018

PET studies in dementia

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000937

Analysis of SPECT brain images for the diagnosis of Alzheimer's disease using moments and support vector machines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000937

Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000937

Longitudinal study of cerebral metabolic asymmetries and associated neuropsychological patterns in early dementia of the Alzheimer type

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000937

Glutamate uptake into astrocytes stimulates aerobic glycolysis: a mechanism coupling neuronal activity to glucose utilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000937

Performance of FDG PET for detection of Alzheimer's disease in two independent multicentre samples (NEST-DD and ADNI).

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000937

A study of regional cerebral blood flow and cognitive performance in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000937

Fully automatic diagnostic system for early- and late-onset mild Alzheimer's disease using FDG PET and 3D-SSP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000937

A multi-center randomized proof-of-concept clinical trial applying [¹⁸F]FDG-PET for evaluation of metabolic therapy with rosiglitazone XR in mild to moderate Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610211000937

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1017/S1041610211000937

1 reference

25 August 2017

1 reference